{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:54:22Z","timestamp":1789570462323,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"funda\u00e7\u00e3o de amparo \u00e0 pesquisa do estado de s\u00e3o paulo","doi-asserted-by":"publisher","award":["2019\/12074-5"],"award-info":[{"award-number":["2019\/12074-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00432-021-03813-1","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T15:58:27Z","timestamp":1633881507000},"page":"107-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact"],"prefix":"10.1007","volume":"148","author":[{"given":"D\u00e9bora","family":"Cabral de Carvalho Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Tesser-Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indhira","family":"Dias Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasjla","family":"Saba da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Maria","family":"Capellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"de Seixas Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Alessandra","family":"Dastoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cavalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3393","authenticated-orcid":false,"given":"Silvia Regina","family":"Caminada de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"3813_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217189","author":"Y Aghajan","year":"2016","unstructured":"Aghajan Y, Levy ML, Malicki DM, Crawford JR (2016) Novel PPP1CB-ALK fusion protein in a high-grade glioma of infancy. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2016-217189","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3813_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ht7040039","volume":"7","author":"AA Ahmed","year":"2018","unstructured":"Ahmed AA, Vundamati DS, Farooqi MS, Guest E (2018) Precision medicine in pediatric cancer: current applications and future prospects. High Throughput 7(4):39. https:\/\/doi.org\/10.3390\/ht7040039","journal-title":"High Throughput"},{"issue":"2","key":"3813_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1(2):e000023. https:\/\/doi.org\/10.1136\/esmoopen-2015-000023","journal-title":"ESMO Open"},{"issue":"suppl3","key":"3813_CR4","doi-asserted-by":"publisher","first-page":"iii351","DOI":"10.1093\/neuonc\/noaa222.324","volume":"22","author":"C Amend","year":"2020","unstructured":"Amend C, Stadler J, Salamat S, Dedekam E, Waanders A, Wadhwani N (2020) Congenital glioblastoma multiforme: a case report of a rare pediatric brain tumor, molecular analysis, and review of the literature. Neuro-Oncol 22(suppl3):iii351. https:\/\/doi.org\/10.1093\/neuonc\/noaa222.324","journal-title":"Neuro-Oncol"},{"issue":"3","key":"3813_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jnen\/nlz140","volume":"79","author":"LY Ballester","year":"2020","unstructured":"Ballester LY, Meis JM, Lazar AJ et al (2020) Intracranial myxoid mesenchymal tumor with EWSR1-ATF1 fusion. J Neuropathol Exp Neurol 79(3):347\u2013351. https:\/\/doi.org\/10.1093\/jnen\/nlz140","journal-title":"J Neuropathol Exp Neurol"},{"key":"3813_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.06.008","author":"M Blattner-Johnson","year":"2021","unstructured":"Blattner-Johnson M, Jones DTW, Pfaff E (2021) Precision medicine in pediatric solid cancers. Semin Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.008","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3813_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11060-017-2393-0","volume":"134","author":"S Braunstein","year":"2017","unstructured":"Braunstein S, Raleigh D, Bindra R, Mueller S, Haas-Kogan D (2017) Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol 134(3):541\u2013549. https:\/\/doi.org\/10.1007\/s11060-017-2393-0","journal-title":"J Neurooncol"},{"issue":"7","key":"3813_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","volume":"10","author":"M Clarke","year":"2020","unstructured":"Clarke M, Mackay A, Ismer B et al (2020) Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov 10(7):942\u2013963. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1030","journal-title":"Cancer Discov"},{"issue":"1","key":"3813_CR9","doi-asserted-by":"publisher","first-page":"vdab016","DOI":"10.1093\/noajnl\/vdab016","volume":"3","author":"SY De Los","year":"2021","unstructured":"De Los SY, Shin D, Malnik S et al (2021) Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy. Neurooncol Adv 3(1):vdab016. https:\/\/doi.org\/10.1093\/noajnl\/vdab016","journal-title":"Neurooncol Adv"},{"issue":"4","key":"3813_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1541-7786.MCR-17-0460","volume":"16","author":"H Deng","year":"2018","unstructured":"Deng H, Zeng J, Zhang T et al (2018) Histone H3.3K27M mobilizes multiple cancer\/testis (ct) antigens in pediatric glioma. Mol Cancer Res 16(4):623\u2013633. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0460","journal-title":"Mol Cancer Res"},{"issue":"8","key":"3813_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.6004\/jnccn.2017.0139","volume":"15","author":"A Drobysheva","year":"2017","unstructured":"Drobysheva A, Klesse LJ, Bowers DC et al (2017) Targeted MAPK pathway inhibitors in patients with disseminated pilocytic astrocytomas. J Natl Compr Canc Netw 15(8):978\u2013982. https:\/\/doi.org\/10.6004\/jnccn.2017.0139","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"3813_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00432-018-02836-5","volume":"145","author":"A Ebrahimi","year":"2019","unstructured":"Ebrahimi A, Skardelly M, Schuhmann MU et al (2019) High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol 145(4):839\u2013850. https:\/\/doi.org\/10.1007\/s00432-018-02836-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"3813_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.wneu.2020.03.212","volume":"139","author":"AI Espiritu","year":"2020","unstructured":"Espiritu AI, Terencio BB, Jamora RDG (2020) Congenital glioblastoma multiforme with long-term childhood survival: a case report and systematic review. World Neurosurg 139:90\u201396. https:\/\/doi.org\/10.1016\/j.wneu.2020.03.212","journal-title":"World Neurosurg"},{"key":"3813_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fonc.2012.00105","volume":"2","author":"J Fangusaro","year":"2012","unstructured":"Fangusaro J (2012) Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2:105. https:\/\/doi.org\/10.3389\/fonc.2012.00105","journal-title":"Front Oncol"},{"issue":"3","key":"3813_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/ijms21030753","volume":"21","author":"A Gambella","year":"2020","unstructured":"Gambella A, Senetta R, Collemi G, Vallero SG, Monticelli M, Cofano F, Zeppa P, Garbossa D, Pellerino A, Rud\u00e0 R, Soffietti R, Fagioli F, Papotti M, Cassoni P, Bertero L (2020) NTRK fusions in central nervous system tumors: a rare, but worthy target. Int J Mol Sci 21(3):753. https:\/\/doi.org\/10.3390\/ijms21030753","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3813_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11060-019-03377-8","volume":"146","author":"A Gilani","year":"2020","unstructured":"Gilani A, Donson A, Davies KD, Whiteway SL, Lake J, DeSisto J, Hoffman L, Foreman NK, Kleinschmidt-DeMasters BK, Green AL (2020) Targetable molecular alterations in congenital glioblastoma. J Neurooncol 146(2):247\u2013252. https:\/\/doi.org\/10.1007\/s11060-019-03377-8","journal-title":"J Neurooncol"},{"issue":"1","key":"3813_CR17","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","volume":"10","author":"AS Guerreiro Stucklin","year":"2019","unstructured":"Guerreiro Stucklin AS et al (2019) Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas. Nat Commun 10(1):4343. https:\/\/doi.org\/10.1038\/s41467-019-12187-5","journal-title":"Nat Commun"},{"issue":"4","key":"3813_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/02688690903158809","volume":"23","author":"D Hargrave","year":"2009","unstructured":"Hargrave D (2009) Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Br J Neurosurg 23(4):351\u2013363. https:\/\/doi.org\/10.1080\/02688690903158809","journal-title":"Br J Neurosurg"},{"issue":"6","key":"3813_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmoldx.2018.06.009","volume":"20","author":"MC Hiemenz","year":"2018","unstructured":"Hiemenz MC, Ostrow DG, Busse TM et al (2018) OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies. J Mol Diagn 20(6):765\u2013776. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.06.009","journal-title":"J Mol Diagn"},{"issue":"1","key":"3813_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a001115","volume":"3","author":"VR Holla","year":"2017","unstructured":"Holla VR, Elamin YY, Bailey AM et al (2017) ALK: a tyrosine kinase target for cancer therapy. Cold Spring Harb Mol Case Stud 3(1):a001115. https:\/\/doi.org\/10.1101\/mcs.a001115","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"4","key":"3813_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jmoldx.2019.03.008","volume":"21","author":"SJ Hsiao","year":"2019","unstructured":"Hsiao SJ, Zehir A, Sireci AN, Aisner DL (2019) Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy. J Mol Diagn 21(4):553\u2013571. https:\/\/doi.org\/10.1016\/j.jmoldx.2019.03.008","journal-title":"J Mol Diagn"},{"issue":"1","key":"3813_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","volume":"5","author":"TY Huang","year":"2017","unstructured":"Huang TY, Piunti A, Lulla RR et al (2017) Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5(1):28. https:\/\/doi.org\/10.1186\/s40478-017-0436-6","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"3813_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Wang G, Liu Y et al (2021) Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm Sin B 11(2):355\u2013372. https:\/\/doi.org\/10.1016\/j.apsb.2020.05.004","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"3813_CR24","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, B\u00e4cklund LM, Ichimura K, Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68(21):8673\u20138677. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2097","journal-title":"Cancer Res"},{"issue":"11","key":"3813_CR25","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00018-011-0898-9","volume":"69","author":"DT Jones","year":"2012","unstructured":"Jones DT, Gronych J, Lichter P, Witt O, Pfister SM (2012) MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci 69(11):1799\u20131811. https:\/\/doi.org\/10.1007\/s00018-011-0898-9","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3813_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/PAS.0000000000000788","volume":"41","author":"YC Kao","year":"2017","unstructured":"Kao YC, Sung YS, Zhang L et al (2017) EWSR1 fusions with creb family transcription factors define a novel myxoid mesenchymal tumor with predilection for intracranial location. Am J Surg Pathol 41(4):482\u2013490. https:\/\/doi.org\/10.1097\/PAS.0000000000000788","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"3813_CR27","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1101\/gad.200907.112","volume":"26","author":"A Kaul","year":"2012","unstructured":"Kaul A, Chen YH, Emnett RJ, Dahiya S, Gutmann DH (2012) Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Genes Dev 26(23):2561\u20132566. https:\/\/doi.org\/10.1101\/gad.200907.112","journal-title":"Genes Dev"},{"issue":"5","key":"3813_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","volume":"129","author":"A Korshunov","year":"2015","unstructured":"Korshunov A, Ryzhova M, Hovestadt V et al (2015) Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 129(5):669\u2013678. https:\/\/doi.org\/10.1007\/s00401-015-1405-4","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3813_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/cancers10040105","volume":"10","author":"AM Lange","year":"2018","unstructured":"Lange AM, Lo HW (2018) Inhibiting TRK proteins in clinical cancer therapy. Cancers (basel) 10(4):105","journal-title":"Cancers (basel)"},{"key":"3813_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.wneu.2020.07.015","volume":"142","author":"C Liu","year":"2020","unstructured":"Liu C, Liu Y, Zhao Y et al (2020) Primary intracranial mesenchymal tumor with ewsr1-crem gene fusion: a case report and literature review. World Neurosurg 142:318\u2013324. https:\/\/doi.org\/10.1016\/j.wneu.2020.07.015","journal-title":"World Neurosurg"},{"issue":"4","key":"3813_CR31","doi-asserted-by":"publisher","first-page":"pky079","DOI":"10.1093\/jncics\/pky079","volume":"2","author":"A Lorentzian","year":"2018","unstructured":"Lorentzian A, Biegel JA, Ostrow DG et al (2018) Tumor variant identification that accounts for the unique molecular landscape of pediatric malignancies. JNCI Cancer Spectr 2(4):pky079. https:\/\/doi.org\/10.1093\/jncics\/pky079","journal-title":"JNCI Cancer Spectr"},{"issue":"8","key":"3813_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"issue":"7","key":"3813_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/neuonc\/nos125","volume":"14","author":"ME Macy","year":"2012","unstructured":"Macy ME, Birks DK, Barton VN, Chan MH, Donson AM, Kleinschmidt-Demasters BK, Bemis LT, Handler MH, Foreman NK (2012) Clinical and molecular characteristics of congenital glioblastoma. Neuro Oncol 14(7):931\u2013941. https:\/\/doi.org\/10.1093\/neuonc\/nos125","journal-title":"Neuro Oncol"},{"issue":"2","key":"3813_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228248","volume":"12","author":"A Ng","year":"2019","unstructured":"Ng A, Levy ML, Malicki DM, Crawford JR (2019) Unusual high-grade and low-grade glioma in an infant with PPP1CB-ALK gene fusion. BMJ Case Rep 12(2):e228248. https:\/\/doi.org\/10.1136\/bcr-2018-228248","journal-title":"BMJ Case Rep"},{"issue":"2","key":"3813_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00381-020-04852-8","volume":"37","author":"VF Oliveira","year":"2021","unstructured":"Oliveira VF, De Sousa GR, Dos Santos AC et al (2021) Evaluating H3F3A K27M and G34R\/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. Childs Nerv Syst 37(2):375\u2013382. https:\/\/doi.org\/10.1007\/s00381-020-04852-8","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"3813_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23(3):261\u2013273. https:\/\/doi.org\/10.3171\/2018.10.PEDS18377","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"3813_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1470-2045(20)30026-7","volume":"21","author":"C Rolfo","year":"2020","unstructured":"Rolfo C (2020) NTRK gene fusions: a rough diamond ready to sparkle. Lancet Oncol 21(4):472\u2013474. https:\/\/doi.org\/10.1016\/S1470-2045(20)30026-7","journal-title":"Lancet Oncol"},{"issue":"7384","key":"3813_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"issue":"6","key":"3813_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00234-010-0699-0","volume":"52","author":"M Severino","year":"2010","unstructured":"Severino M, Schwartz ES, Thurnher MM, Rydland J, Nikas I, Rossi A (2010) Congenital tumors of the central nervous system. Neuroradiology 52(6):531\u2013548. https:\/\/doi.org\/10.1007\/s00234-010-0699-0","journal-title":"Neuroradiology"},{"key":"3813_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00005072-196404000-00004","volume":"23","author":"GB Solitare","year":"1964","unstructured":"Solitare GB, Krigman MR (1964) Congenital intracranial neoplasm. A case report and review of the literature. J Neuropathol Exp Neurol 23:280\u2013292","journal-title":"J Neuropathol Exp Neurol"},{"key":"3813_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.574974","volume":"10","author":"K Srinivasa","year":"2020","unstructured":"Srinivasa K, Cross KA, Dahiya S (2020) BRAF alteration in central and peripheral nervous system tumors. Front Oncol 10:574974. https:\/\/doi.org\/10.3389\/fonc.2020.574974","journal-title":"Front Oncol"},{"issue":"4","key":"3813_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425\u2013437. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.024","journal-title":"Cancer Cell"},{"issue":"2","key":"3813_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrc3655","volume":"14","author":"D Sturm","year":"2014","unstructured":"Sturm D, Bender S, Jones DT et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14(2):92\u2013107. https:\/\/doi.org\/10.1038\/nrc3655","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3813_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.11477\/mf.1436204438","volume":"49","author":"K Terashima","year":"2021","unstructured":"Terashima K, Ogiwara H (2021) No shinkei geka. Neurol Surg 49(3):640\u2013646. https:\/\/doi.org\/10.11477\/mf.1436204438","journal-title":"Neurol Surg"},{"issue":"5","key":"3813_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bpa.12042","volume":"23","author":"S Venneti","year":"2013","unstructured":"Venneti S, Garimella MT, Sullivan LM et al (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23(5):558\u2013564. https:\/\/doi.org\/10.1111\/bpa.12042","journal-title":"Brain Pathol"},{"issue":"8","key":"3813_CR46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/neuonc\/noab120","volume":"23","author":"PY Wen","year":"2021","unstructured":"Wen PY, Packer RJ (2021) The 2021 WHO classification of tumors of the central nervous system: clinical implications. Neuro Oncol 23(8):1215\u20131217. https:\/\/doi.org\/10.1093\/neuonc\/noab120","journal-title":"Neuro Oncol"},{"key":"3813_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2017.00033","volume":"7","author":"A Wong","year":"2017","unstructured":"Wong A (2017) The emerging role of targeted therapy and immunotherapy in the management of brain metastases in non-small cell lung cancer. Front Oncol 7:33. https:\/\/doi.org\/10.3389\/fonc.2017.00033","journal-title":"Front Oncol"},{"issue":"5","key":"3813_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G, Diaz AK, Paugh BS et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46(5):444\u2013450. https:\/\/doi.org\/10.1038\/ng.2938","journal-title":"Nat Genet"},{"issue":"5","key":"3813_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccr.2013.09.015","volume":"24","author":"BT Yuen","year":"2013","unstructured":"Yuen BT, Knoepfler PS (2013) Histone H3.3 mutations: a variant path to cancer. Cancer Cell 24(5):567\u2013574. https:\/\/doi.org\/10.1016\/j.ccr.2013.09.015","journal-title":"Cancer Cell"},{"key":"3813_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cancergen.2020.12.005","volume":"252\u2013253","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Lin F, Xu F, Schubert J, Wu J, Wainwright L, Zhao X, Cao K, Fan Z, Chen J, Lang SS, Kennedy BC, Viaene AN, Santi M, Resnick AC, Storm PB, Li MM (2021) Genomic characterization of a PPP1CB-ALK fusion with fusion gene amplification in a congenital glioblastoma. Cancer Genet 252\u2013253:37\u201342. https:\/\/doi.org\/10.1016\/j.cancergen.2020.12.005","journal-title":"Cancer Genet"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03813-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T13:09:33Z","timestamp":1641906573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03813-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03813-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"14 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee (Committee for Ethics in Research\u2014Federal University of Sao Paulo no. 0915\/2019). This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Samples from each primary tumor were collected after informed consent was signed by patients\/guardians according to the Institutional Research Committee (Committee for Ethics in Research\u2014Federal University of Sao Paulo no. 0915\/2019). The biological material is acquired via a Biobank of the Pediatric Oncology Institute-GRAACC\/UNIFESP (National Commission of Ethics in Research\u2014CONEP B-053).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}